Latest numbers show antimicrobial resistant infections contributed to 4.95 million deaths globally in 2019.
Workers from a syringe-making company in Kilifi, Kenya have been changing minds around the COVID-19 vaccine.
With more than half of all Europeans predicted to be infected with COVID-19 in the next two months, and perceptions of it being mild, it might be tempting to think it’s better to get the infection over with. Here’s why that is a dangerous game to…
COVAX, the vaccine pillar of the Access to COVID-19 Tools Accelerator (ACT-Accelerator), has now shipped over 1 billion doses to 144 countries and territories.
In November 2021 Kenya’s Kisumu County launched a large scale measles-rubella vaccine campaign to reach 100% of unvaccinated children.
Access to COVID-19 vaccines has been made easier in the Kingdom of Eswatini as residents can get their jab at bus stops and taxi ranks across the country.
COVAX and the other international organizations committed to vaccine equity cannot end the COVID-19 pandemic without the continued support of governments, industry, and civil society. By working together, the world has a chance to tame the…
As the Omicron variant of COVID-19 continues to spread around the world, here’s what you need to know about its symptoms.
Growing numbers of countries are cutting the isolation period for people who test positive for COVID-19, but what does the science say about how long people remain infectious for?
COVID-19 has hit routine immunisation hard in southern Nigeria. Authorities are now working hard to ensure children don’t miss out.
Civil society, media, local influencers, celebrities, religious scholars, and frontline workers are all reinforcing the Pakistan government’s fight against Poliomyelitis.
3.6 million people have still not had even their first dose of COVID-19 vaccine. Ensuring every adult has received at least one dose should be our focus for 2022.